Robbins and Judges (2009), defines decision making as “the choice we make when are faced with a problem from among two or more alternatives (Robbins & Judge, 2009).” The way individuals make decisions and the quality of their choices are largely influenced by their perceptions (Robbins & Judge, 2009). Within the healthcare industry, decisions are constantly being made by practitioners, patients, and investors for a better outcome of patient care. Whenever a new product or drug with the potential to change healthcare is introduced, especially those that create a simple solution to extremely complex problems, the outcry is always great for all concerned parties. Take for instance Theranos – a company whose initiative was to make obtaining blood test faster, easier, and at a low cost – a dream come true for every stakeholder in thehealthcare industry. Theranos made its first public debut in 2013 when it announced its partnership with Walgreens – introducing its wellness centers as a place where patients can get various blood tests done (Kolhatkar & Chen, 2015). Preceding Theranos public appearance, it had secretly been in existence for 10 years “hiring scientists, building prototypes, and lobbying the Arizona State Legislature to make it legal for individuals to order lab tests without a prescription …show more content…
Their decision to foster the invention without proper scientific research, showed that they sought out to validate Holmes information and ignored the evidence that could demerit her findings. Investors accepted “the face value information that confirms preconceived views while being skeptical and critical of information that challenges them (Robbins & Judge,